[HTML][HTML] [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT
X Mu, X Huang, Z Jiang, M Li, L Jia, Z Lv, W Fu… - European Journal of …, 2023 - Springer
Purpose This study aimed to assess the diagnostic performance of [18F] FAPI-42 PET/CT
and compare it with that of 2-[18F] FDG PET/CT in patients with differentiated thyroid cancer …
and compare it with that of 2-[18F] FDG PET/CT in patients with differentiated thyroid cancer …
The role of radioactive iodine in the management of patients with differentiated thyroid cancer–an oncologic surgical perspective
With improved understanding of the biology of differentiated thyroid carcinoma its
management is evolving. The approach to surgery for the primary tumour and elective nodal …
management is evolving. The approach to surgery for the primary tumour and elective nodal …
The efficacy of adjuvant radioactive iodine after reoperation in patients with persistent or recurrent differentiated thyroid cancer: a systematic review
J Raghupathy, BKJ Tan, HJ Song, AZQ Chia… - … Archives of Surgery, 2023 - Springer
Objective The effectiveness of adjuvant radioiodine (RAI) after reoperation in patients with
persistent or recurrent differentiated thyroid cancer (DTC) is controversial. Although various …
persistent or recurrent differentiated thyroid cancer (DTC) is controversial. Although various …
Use of confidence intervals in interpreting nonstatistically significant results
AT Hawkins, LR Samuels - JAMA, 2021 - jamanetwork.com
The goal of much of medical research is to determine which of 2 or more therapeutic
approaches is most effective in a given situation. The power of a study is the probability of …
approaches is most effective in a given situation. The power of a study is the probability of …
[HTML][HTML] Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
N Liang, H Zhang, C Sui, R Du, C Li, J Li… - Frontiers in …, 2023 - frontiersin.org
Background Despite improvements in overall survival, the recurrence of differentiated
thyroid cancer (DTC) is becoming more common and remains a challenge necessitating …
thyroid cancer (DTC) is becoming more common and remains a challenge necessitating …
[HTML][HTML] The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma
W Sun, L Di, L Chen, D Li, Y Wu, J Xiang, S Zhou… - BMC surgery, 2022 - Springer
Background While the most suitable approach for treating persistent/recurrent papillary
thyroid carcinoma (PTC) remains controversial, reoperation may be considered an effective …
thyroid carcinoma (PTC) remains controversial, reoperation may be considered an effective …
Low expression of TFF3 in papillary thyroid carcinoma may correlate with poor prognosis but high immune cell infiltration
L Yang, X Zhang, J Zhang, Y Liu, T Ji, J Mou… - Future …, 2021 - Future Medicine
Background: Papillary thyroid carcinoma (PTC) is one of the most common endocrine
malignancies and has a favorable prognosis. However, optimal treatments and prognostic …
malignancies and has a favorable prognosis. However, optimal treatments and prognostic …
Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: a …
P Weslley Rosario, G Franco Mourão… - Endocrine, 2020 - Springer
Background Most patients with papillary thyroid cancer (PTC) and lymph node metastases
(LNM) undergoing reoperation do not show apparent disease after this procedure, but …
(LNM) undergoing reoperation do not show apparent disease after this procedure, but …
[HTML][HTML] Long noncoding RNA SNHG6 promotes papillary thyroid cancer cells proliferation via regulating miR-186/CDK6 axis
J Xu, M Liao - Gland Surgery, 2021 - ncbi.nlm.nih.gov
Background Papillary thyroid cancer (PTC) is a common endocrine malignancy, and its
incidence rate has been increasing in recent years. Long noncoding RNAs (lncRNAs) …
incidence rate has been increasing in recent years. Long noncoding RNAs (lncRNAs) …
Utility of adjuvant radioactive iodine therapy after reoperation in papillary thyroid carcinoma with cervical lymph node recurrence
Y Zhang, X Zhu, Q Fan, Q Huang, Y Tu, L Jiang… - Japanese Journal of …, 2023 - Springer
Purpose The aim of this study was to evaluate the utility of RAI therapy after reoperation for
patients with LN relapse. Materials and methods We retrospectively evaluated PTC patients …
patients with LN relapse. Materials and methods We retrospectively evaluated PTC patients …